Will Pfizer Be Worth More Than Tesla by 2025?
Only about a year ago, we may have asked the opposite question: Will electric-car maker Tesla's market cap surpass that of pharmaceutical giant Pfizer (NYSE: PFE) one day? Pfizer's market value totaled about $200 billion. And at its lowest point last spring, Tesla's market cap dipped to $84 billion.
A lot has happened since then. Pfizer became the first to commercialize a coronavirus vaccine -- and that vaccine is generating billions of dollars in revenue. And Tesla delivered of a half a million cars in 2020. So far, investors have rewarded Tesla more than they've rewarded Pfizer. Tesla's market cap soared 794% last year -- well surpassing that of Pfizer. Now the question is whether the pharmaceutical company can transform strong revenue into share gains -- and top Tesla's market value.
Image source: Getty Images.
Source Fool.com
